Jounce Therapeutics Appoints Deborah Law, D.Phil., To Chief Scientific Officer

Jounce Therapeutics, Inc., a company focused on the discovery and development of novel cancer immunotherapies coupled to patient selection strategies, today announced the appointment of Deborah Law, D. Phil., to the position of chief scientific officer. Dr. Law brings to Jounce nearly two decades of experience in biologics drug discovery and development, particularly in the fields of oncology and immunology.

Help employers find you! Check out all the jobs and post your resume.